{"id":"https://openalex.org/W7225784672","doi":"https://doi.org/10.1038/s41591-026-04716-9","title":"Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer","display_name":"Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225784672","doi":"https://doi.org/10.1038/s41591-026-04716-9"},"language":"en","primary_location":{"id":"doi:10.1038/s41591-026-04716-9","doi":"https://doi.org/10.1038/s41591-026-04716-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41591-026-04716-9","pdf_url":null,"source":{"id":"https://openalex.org/S203256638","display_name":"Nature Medicine","issn_l":"1078-8956","issn":["1078-8956","1546-170X","1744-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1038/s41591-026-04716-9","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091509029","display_name":"Marina Chiara Garassino","orcid":"https://orcid.org/0000-0002-3821-5598","observed_orcids":["https://orcid.org/0000-0002-3821-5598"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina C. Garassino","raw_affiliation_strings":["The University of Chicago, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034739279","display_name":"Myung\u2010Ju Ahn","orcid":"https://orcid.org/0000-0002-5740-9654","observed_orcids":["https://orcid.org/0000-0002-5740-9654","https://orcid.org/0000-0002-5376-5109"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Myung-Ju Ahn","raw_affiliation_strings":["Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018550667","display_name":"Markus Schick","orcid":"https://orcid.org/0009-0003-8626-0611","observed_orcids":["https://orcid.org/0009-0003-8626-0611"]},"institutions":[{"id":"https://openalex.org/I4210159719","display_name":"AstraZeneca (Germany)","ror":"https://ror.org/054q96n74","country_code":"DE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210159719"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus Schick","raw_affiliation_strings":["Computational Pathology, AstraZeneca, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational Pathology, AstraZeneca, Munich, Germany","institution_ids":["https://openalex.org/I4210159719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076486250","display_name":"Ansh Kapil","orcid":"https://orcid.org/0000-0002-5079-6997","observed_orcids":["https://orcid.org/0000-0002-5079-6997"]},"institutions":[{"id":"https://openalex.org/I4210159719","display_name":"AstraZeneca (Germany)","ror":"https://ror.org/054q96n74","country_code":"DE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210159719"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ansh Kapil","raw_affiliation_strings":["Computational Pathology, AstraZeneca, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational Pathology, AstraZeneca, Munich, Germany","institution_ids":["https://openalex.org/I4210159719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052765751","display_name":"Luis G Paz-Ares","orcid":"https://orcid.org/0000-0002-1947-3364","observed_orcids":["https://orcid.org/0000-0002-1947-3364"]},"institutions":[{"id":"https://openalex.org/I121748325","display_name":"Universidad Complutense de Madrid","ror":"https://ror.org/02p0gd045","country_code":"ES","type":"education","lineage":["https://openalex.org/I121748325"]},{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis Paz-Ares","raw_affiliation_strings":["Universidad Complutense and CiberOnc, Hospital Universitario 12 de Octubre, Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0002-1947-3364","affiliations":[{"raw_affiliation_string":"Universidad Complutense and CiberOnc, Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I121748325","https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078435189","display_name":"Aaron Elliott Lisberg","orcid":"https://orcid.org/0000-0003-3048-4352","observed_orcids":["https://orcid.org/0000-0003-3048-4352"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4390039293","display_name":"UCLA Jonsson Comprehensive Cancer Center","ror":"https://ror.org/0599cs764","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4390039293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Lisberg","raw_affiliation_strings":["Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4390039293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049294543","display_name":"Melissa Lynne Johnson","orcid":"https://orcid.org/0000-0001-9874-1314","observed_orcids":["https://orcid.org/0000-0001-9874-1314"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa L. Johnson","raw_affiliation_strings":["Sarah Cannon Research Institute, Nashville, TN, USA"],"raw_orcid":"https://orcid.org/0000-0001-9874-1314","affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043045128","display_name":"Maurice P\u00e9rol","orcid":"https://orcid.org/0000-0002-3296-423X","observed_orcids":["https://orcid.org/0000-0002-3296-423X"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210125048","display_name":"Centre de Recherche en Canc\u00e9rologie de Lyon","ror":"https://ror.org/02mgw3155","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I4210096427","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maurice P\u00e9rol","raw_affiliation_strings":["L\u00e9on-B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":"https://orcid.org/0000-0002-3296-423X","affiliations":[{"raw_affiliation_string":"L\u00e9on-B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161473797","display_name":"Toshio Shimizu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405284950","display_name":"Kansai Medical University Hospital","ror":"https://ror.org/04gpc9445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284950"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Shimizu","raw_affiliation_strings":["National Cancer Centre Hospital, Kansai Medical University Hospital, Hirakata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Centre Hospital, Kansai Medical University Hospital, Hirakata, Japan","institution_ids":["https://openalex.org/I4405284950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064382279","display_name":"Rebecca Suk Heist","orcid":"https://orcid.org/0000-0002-7397-2009","observed_orcids":["https://orcid.org/0000-0002-7397-2009"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Heist","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112618716","display_name":"Alexander I. Spira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122908","display_name":"Virginia Cancer Specialists","ror":"https://ror.org/03tbabt10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210122908"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Spira","raw_affiliation_strings":["Virginia Cancer Specialists (VCS) Research Institute, Fairfax, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Cancer Specialists (VCS) Research Institute, Fairfax, VA, USA","institution_ids":["https://openalex.org/I4210122908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110475334","display_name":"Isamu Okamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097767","display_name":"Kyushu University Hospital","ror":"https://ror.org/00ex2fc97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Isamu Okamoto","raw_affiliation_strings":["Kyushu University Hospital, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyushu University Hospital, Fukuoka, Japan","institution_ids":["https://openalex.org/I4210097767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090329560","display_name":"Nicolas Girard","orcid":"https://orcid.org/0000-0001-9909-2299","observed_orcids":["https://orcid.org/0000-0001-9909-2299","https://orcid.org/0000-0002-7636-6688"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Girard","raw_affiliation_strings":["Institut Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051331698","display_name":"Robin Cornelissen","orcid":"https://orcid.org/0000-0002-4289-3092","observed_orcids":["https://orcid.org/0000-0002-4289-3092"]},"institutions":[{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Robin Cornelissen","raw_affiliation_strings":["Erasmus MC Cancer Institute, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erasmus MC Cancer Institute, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I4210149908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010990336","display_name":"Elvire Pons Tostivint","orcid":"https://orcid.org/0000-0003-4478-0523","observed_orcids":["https://orcid.org/0000-0003-4478-0523"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Elvire Pons-Tostivint","raw_affiliation_strings":["University Hospital of Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Nantes, Nantes, France","institution_ids":["https://openalex.org/I3019204325","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011980528","display_name":"Min Hee Hong","orcid":"https://orcid.org/0000-0003-3490-2195","observed_orcids":["https://orcid.org/0000-0003-3490-2195"]},"institutions":[{"id":"https://openalex.org/I2799970807","display_name":"Severance Hospital","ror":"https://ror.org/044kjp413","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Min Hee Hong","raw_affiliation_strings":["Yonsei Cancer Center, Severance Hospital, Seoul, Republic of Korea"],"raw_orcid":"https://orcid.org/0000-0003-3490-2195","affiliations":[{"raw_affiliation_string":"Yonsei Cancer Center, Severance Hospital, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I2799970807","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084647341","display_name":"Ricardo F. Zwirtes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162815","display_name":"Daiichi Sankyo (United States)","ror":"https://ror.org/055werx92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo Zwirtes","raw_affiliation_strings":["Clinical Development, Daiichi Sankyo, Basking Ridge, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Daiichi Sankyo, Basking Ridge, NJ, USA","institution_ids":["https://openalex.org/I4210162815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022694604","display_name":"Rachel A. Chiaverelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162815","display_name":"Daiichi Sankyo (United States)","ror":"https://ror.org/055werx92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Chiaverelli","raw_affiliation_strings":["Translational Medicine, Daiichi Sankyo, Basking Ridge, NJ, USA"],"raw_orcid":"https://orcid.org/0009-0002-3950-9843","affiliations":[{"raw_affiliation_string":"Translational Medicine, Daiichi Sankyo, Basking Ridge, NJ, USA","institution_ids":["https://openalex.org/I4210162815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109358604","display_name":"Marlon Cezar Rebelatto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marlon Rebelatto","raw_affiliation_strings":["Translational Pathology, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Pathology, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023348910","display_name":"Matthew S. Sung","orcid":"https://orcid.org/0009-0003-8443-039X","observed_orcids":["https://orcid.org/0009-0003-8443-039X"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Sung","raw_affiliation_strings":["Oncology Targeted Discovery, AstraZeneca, Waltham, MA, USA"],"raw_orcid":"https://orcid.org/0009-0003-8443-039X","affiliations":[{"raw_affiliation_string":"Oncology Targeted Discovery, AstraZeneca, Waltham, MA, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028981296","display_name":"Chuyu Deng","orcid":"https://orcid.org/0000-0002-8353-9700","observed_orcids":["https://orcid.org/0000-0002-8353-9700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chuyu Deng","raw_affiliation_strings":["Biometrics, Oncology R&D, AstraZeneca, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biometrics, Oncology R&D, AstraZeneca, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109116400","display_name":"James A. Harper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Harper","raw_affiliation_strings":["Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046909219","display_name":"Danielle K. Carroll","orcid":"https://orcid.org/0009-0002-0297-4119","observed_orcids":["https://orcid.org/0009-0002-0297-4119"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Danielle Carroll","raw_affiliation_strings":["Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014716846","display_name":"Hadassah Sade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159719","display_name":"AstraZeneca (Germany)","ror":"https://ror.org/054q96n74","country_code":"DE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210159719"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Hadassah Sade","raw_affiliation_strings":["Computational Pathology, AstraZeneca, Munich, Germany"],"raw_orcid":"https://orcid.org/0009-0001-0634-2584","affiliations":[{"raw_affiliation_string":"Computational Pathology, AstraZeneca, Munich, Germany","institution_ids":["https://openalex.org/I4210159719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054580205","display_name":"Jacob M. Sands","orcid":"https://orcid.org/0000-0003-4663-7464","observed_orcids":["https://orcid.org/0000-0003-4663-7464"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob Sands","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":25,"corresponding_author_ids":["https://openalex.org/A5014716846"],"corresponding_institution_ids":["https://openalex.org/I4210159719"],"apc_list":{"value":12690,"currency":"USD","value_usd":12690},"apc_paid":{"value":12690,"currency":"USD","value_usd":12690},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7897999882698059},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7289999723434448},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6897000074386597},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6712999939918518},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6287000179290771},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5795999765396118},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5726000070571899},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5012999773025513},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49230000376701355},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39419999718666077},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.39070001244544983},{"id":"https://openalex.org/C20417620","wikidata":"https://www.wikidata.org/wiki/Q4140229","display_name":"Glutamate carboxypeptidase II","level":4,"score":0.3732999861240387},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3449999988079071},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3149000108242035},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.31369999051094055},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2930000126361847},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.28200000524520874},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2802000045776367},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2786000072956085},{"id":"https://openalex.org/C2776677690","wikidata":"https://www.wikidata.org/wiki/Q5383694","display_name":"Epithelial cell adhesion molecule","level":3,"score":0.2734000086784363},{"id":"https://openalex.org/C3020640247","wikidata":"https://www.wikidata.org/wiki/Q1981379","display_name":"Chinese population","level":4,"score":0.2526000142097473}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1038/s41591-026-04716-9","doi":"https://doi.org/10.1038/s41591-026-04716-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41591-026-04716-9","pdf_url":null,"source":{"id":"https://openalex.org/S203256638","display_name":"Nature Medicine","issn_l":"1078-8956","issn":["1078-8956","1546-170X","1744-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1038/s41591-026-04716-9","doi":"https://doi.org/10.1038/s41591-026-04716-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41591-026-04716-9","pdf_url":null,"source":{"id":"https://openalex.org/S203256638","display_name":"Nature Medicine","issn_l":"1078-8956","issn":["1078-8956","1546-170X","1744-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W1486001319","https://openalex.org/W1635741485","https://openalex.org/W1986057859","https://openalex.org/W2010747774","https://openalex.org/W2045306661","https://openalex.org/W2093700012","https://openalex.org/W2104285855","https://openalex.org/W2115709314","https://openalex.org/W2232399331","https://openalex.org/W2312123827","https://openalex.org/W2474739399","https://openalex.org/W2590751956","https://openalex.org/W2598869148","https://openalex.org/W2619867544","https://openalex.org/W2770828094","https://openalex.org/W2787894218","https://openalex.org/W2809327804","https://openalex.org/W2917113139","https://openalex.org/W2964309882","https://openalex.org/W2964756323","https://openalex.org/W2970782214","https://openalex.org/W3006555820","https://openalex.org/W3034785488","https://openalex.org/W3087210493","https://openalex.org/W3128131226","https://openalex.org/W3130337937","https://openalex.org/W3136371193","https://openalex.org/W3137946808","https://openalex.org/W3161602430","https://openalex.org/W3196123505","https://openalex.org/W4206545984","https://openalex.org/W4211059596","https://openalex.org/W4282934869","https://openalex.org/W4294953564","https://openalex.org/W4304780383","https://openalex.org/W4308179948","https://openalex.org/W4316810205","https://openalex.org/W4322774995","https://openalex.org/W4379339845","https://openalex.org/W4380881366","https://openalex.org/W4382799163","https://openalex.org/W4386743405","https://openalex.org/W4387523710","https://openalex.org/W4387825677","https://openalex.org/W4388091164","https://openalex.org/W4391303295","https://openalex.org/W4395027993","https://openalex.org/W4399042410","https://openalex.org/W4399274593","https://openalex.org/W4399806455","https://openalex.org/W4400036512","https://openalex.org/W4402350756","https://openalex.org/W4402472398","https://openalex.org/W4402559945","https://openalex.org/W4406090459","https://openalex.org/W4406413355","https://openalex.org/W4408989317","https://openalex.org/W4409912954","https://openalex.org/W4410803089","https://openalex.org/W4411227366","https://openalex.org/W4415444413","https://openalex.org/W4415520301","https://openalex.org/W7138035728","https://openalex.org/W7138459683","https://openalex.org/W7157575302"],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Datopotamab":[1],"deruxtecan":[2],"(Dato-DXd)\u2014a":[3],"trophoblast":[4],"cell":[5,84],"surface":[6],"antigen":[7],"2":[8],"(TROP2)-directed":[9],"antibody\u2013drug":[10,45],"conjugate\u2014has":[11],"demonstrated":[12],"efficacy":[13],"in":[14,47,65,103,112,128,143,165],"patients":[15,108,129,194],"with":[16,36,109,130,156,195],"advanced":[17,110],"nonsquamous":[18,131],"non-small-cell":[19],"lung":[20],"cancer":[21],"(NSCLC)":[22],"\u00b1":[23],"actionable":[24,134],"genomic":[25,135],"alterations.":[26],"However,":[27],"TROP2":[28,51,63,79,121,196,199,212],"expression":[29,64,80],"by":[30,203],"pathologist":[31],"assessment":[32],"using":[33],"conventional":[34],"immunohistochemistry":[35],"visual":[37],"scoring":[38,54],"does":[39],"not":[40,180],"predict":[41],"response":[42],"to":[43,77,98],"TROP2-directed":[44],"conjugates":[46],"NSCLC.":[48],"We":[49],"developed":[50,93],"quantitative":[52],"continuous":[53],"(QCS)\u2014a":[55],"fully":[56],"supervised":[57],"computational":[58],"pathology":[59],"approach":[60],"that":[61,211],"quantifies":[62],"individual":[66],"NSCLC":[67,111,132],"cells":[68],"and":[69,86,126],"subcellular":[70],"components":[71],"from":[72],"immunohistochemistry-stained":[73],"slides.":[74],"Using":[75],"QCS":[76],"determine":[78],"at":[81],"the":[82,104,113,144,152],"tumor":[83],"membrane":[85,89,96,99],"cytoplasm,":[87],"normalized":[88],"ratio":[90,173,188],"(NMR)":[91],"was":[92,124,159,163],"(ratio":[94],"of":[95,107,151],"relative":[97],"+":[100],"cytoplasmic":[101],"TROP2)":[102],"biomarker-evaluable":[105,145],"population":[106,146],"TROPION-PanTumor01":[114],"study":[115],"(":[116,147],"n":[117,140,148],"=":[118,141,149,208],"115).":[119],"The":[120],"NMR":[122,213],"cut-point":[123],"optimized":[125],"validated":[127],"without":[133],"alterations":[136],"(primary":[137],"intended-use":[138],"population,":[139],"221)":[142],"352)":[150],"TROPION-Lung01":[153],"trial.":[154],"Association":[155],"clinical":[157],"outcomes":[158],"assessed.":[160],"Progression-free":[161],"survival":[162],"longer":[164],"Dato-DXd-treated":[166],"(median":[167,182],"7.2":[168],"versus":[169,184,198],"4.0":[170],"months;":[171,186],"hazard":[172,187],"0.40,":[174],"95%":[175,190],"confidence":[176,191],"interval":[177,192],"0.25\u20130.64)":[178],"but":[179],"docetaxel-treated":[181],"4.1":[183],"4.4":[185],"0.94,":[189],"0.59\u20131.49)":[193],"NMR-positive":[197],"NMR-negative":[200],"samples":[201],"(treatment":[202],"biomarker":[204,218],"status":[205],"interaction":[206],"P":[207],"0.0098),":[209],"indicating":[210],"may":[214],"be":[215],"a":[216],"predictive":[217],"for":[219],"Dato-DXd.":[220]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}